The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and1H MR Spectroscopy
Abstract
Magnetic resonance (MR) imaging and hydrogen 1 MR spectroscopy of the prostate gland are performed during the same examination with a conventional clinical MR unit. Prostate zonal anatomy and prostate cancer are best depicted on multiplanar T2-weighted MR images. MR imaging and 1H MR spectroscopy are not used as an initial diagnostic tool. Their use in tumor detection is reserved for patients with elevated prostate-specific antigen levels in whom previous biopsy results were negative. The use of MR imaging and 1H MR spectroscopy for the evaluation of tumor location, local extent (extracapsular extension and/or seminal vesicle invasion), volume, and aggressiveness is generating strong clinical interest. In staging and treatment planning, MR imaging has been shown to have an incremental value additive to the value of clinical nomograms. Furthermore, anatomic and metabolic mapping of the prostate gland with 1H MR spectroscopy offers the possibility of optimizing treatment planning (watchful waiting, surgery, or radiation therapy [intensity-modulated radiation therapy or brachytherapy]), thus further expanding the role of MR imaging in the achievement of patient-specific, individualized treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Cited by
Mesoporous silica nanoparticles in drug delivery and biomedical applications
Wang, Y., Zhao, Q., Han, N., Bai, L., Li, J., Liu, J., Che, E., Hu, L., Zhang, Q., Jiang, T., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.09.014 · Cited by 1,192
Imaging Prostate Cancer: A Multidisciplinary Perspective
Hricak, H., Choyke, P. L., Eberhardt, S. C., Leibel, S. A., & Scardino, P. T. (2007) · Radiology · doi:10.1148/radiol.2431030580 · Cited by 601
Self-citationAkin, O., Sala, E., Moskowitz, C. S., Kuroiwa, K., Ishill, N. M., Pucar, D., Scardino, P. T., & Hricak, H. (2006) · Radiology · doi:10.1148/radiol.2392050949 · Cited by 379
Self-citationMultiscale observation of biological interactions of nanocarriers: From nano to macro
Jin, S., Bae, J. W., & Hong, S. (2010) · Microscopy Research and Technique · doi:10.1002/jemt.20847 · Cited by 42
Metadata
- Authors
- Claus, F. G., Hricak, H., & Hattery, R. R.
- Venue
- RadioGraphics
- Published
- 2004-10
- Volume
- 24
- Issue
- suppl_1
- Pages
- S167-S180
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2157585349
- Cited by
- 158
- References
- 1
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and1H MR Spectroscopy. https://app.cochat.ai/papers/10.1148/24si045516
- The paper
- Claus, F. G., Hricak, H., & Hattery, R. R. (2004). Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and1H MR Spectroscopy. RadioGraphics. https://doi.org/10.1148/24si045516
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.